> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Durbin, Grassley Push Drug Ad Transparency Bill
- URL: https://www.fdaweb.com/durbin-grassley-push-drug-ad-transparency-bill/
- Published: 2023-11-29T12:00:00.000Z
- Updated: 2026-09-14T14:17:20.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5155887

Sens. **Dick Durbin** (D-IL) and **Charles Grassley** (R-IA) asked the Senate on 11/28 for unanimous consent to pass their bipartisan Drug-price Transparency for Consumers (DTC) Act that would require list price disclosures in ads for prescription drugs. A [statement](https://www.durbin.senate.gov/newsroom/press-releases/durbin-joins-grassley-in-attempt-to-pass-bipartisan-bill-to-require-price-transparency-in-prescription-drug-advertisements?ref=fdaweb.com) from Durbin says Sen. **Mike Crapo** (R-ID) objected to the unanimous consent request.

In his statement, Durbin said pharmaceutical manufacturers spend more than $6 billion on drug ads, equal to FDA’s total budget. “Senator Grassley and I think it’s time for Big Pharma to end the secrecy about the real cost of these drugs,” he said. “If they’re advertising a drug, they should disclose the price up front. It is a basic transparency measure for patients.”